![](/img/cover-not-exists.png)
Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS Clinical Trial
Yuzuru Kanakura, Kazuma Ohyashiki, Tsutomu Shichishima, Shinichiro Okamoto, Kiyoshi Ando, Haruhiko Ninomiya, Tatsuya Kawaguchi, Shinji Nakao, Hideki Nakakuma, Jun-ichi Nishimura, Taroh Kinoshita, CamiVolume:
93
Language:
english
Pages:
11
DOI:
10.1007/s12185-010-0748-9
Date:
January, 2011
File:
PDF, 307 KB
english, 2011